Explorer les evidences

1 189 casesPatent parasitaemia at baseline was present in 1,189 children (68.3%) among 1,740 febrile children enrolled across study sites in Ghana, Nigeria, and Uganda.

Ghana · Nigeria · Ougandapaludismepublié 2008Malaria journaleurope_pmcdocument de 9 observationsDOI 10.1186/1475-2875-7-190

10,2 %The prevalence of Plasmodium infection in blood donors in Ghana was 10.20%.

GhanapaludismeHAL · Unilimdocument de 148 observations

3 000 000 000 peopleMore than three thousand million people live with the risk of malaria.

GhanapaludismeHAL · Unilimdocument de 40 observations

Adjei et al. in Ghana and Gbessi et al. in Côte d’Ivoire reported decreased efficacy of ACT in sickle cell patients correlated with a delay in P. falciparum clearance.

GhanapaludismeHAL · Unilimdocument de 59 observations

The RTS,S/ASO1E malaria vaccine is being piloted in Ghana, Kenya, and Malawi.

Ghana · Kenya · Malawipaludismepublié 2021PloS onePubMeddocument de 7 observations

33,8 %Au Ghana, la prévalence des infections submicroscopiques à Plasmodium spp. était de 33,8 % selon Amoah et al.

GhanapaludismeHAL · Unilimdocument de 64 observations

5,7 USDIn Ghana, the treatment cost for each malaria episode varies from USD 5.70 to USD 48.73, depending on disease severity.

GhanapaludismeHAL · Unilimdocument de 40 observations

1 344 cases_averted_per_1000_childrenIn a phase 2b trial in Ghana and Kenya, vaccine impact of the RTS,S malaria vaccine, measured as cumulative number of clinical malaria cases averted per 1000 children vaccinated at month 32 post-dose 1, was 1344 for group R012-20.

Ghana · Kenyapaludismepublié 2024The Journal of infectious diseasesPubMeddocument de 9 observations

336 cases_averted_per_1000_full_dose_equivalentsIn a phase 2b trial in Ghana and Kenya, vaccine impact of the RTS,S malaria vaccine, measured as cumulative number of clinical malaria cases averted per 1000 RTS,S full-dose equivalents at month 32 post-dose 1, was 336 for group R012-20.

Ghana · Kenyapaludismepublié 2024The Journal of infectious diseasesPubMeddocument de 9 observations

50 000 episodesOver 50,000 episodes of uncomplicated malaria among children aged 12–59 months were included in the study.

Ghanapaludismepublié 2024Malaria journalPubMeddocument de 4 observations

25,72 nMSulfadoxine was less potent against Plasmodium malariae than Plasmodium falciparum in Ghana, with IC50 values of 25.72 nM versus 7.86 nM.

Ghanapaludismepublié 2025Microbiology spectrumeurope_pmcdocument de 5 observations

33 %Uncomplicated malaria was reduced by 33% over the entire study period (2020–2022) among children aged 12–59 months in the implementing districts of the Upper East Region, Ghana.

Ghanapaludismeobservé 2020-2022publié 2024Malaria journalPubMeddocument de 4 observations

10 591 patients10,591 patients aged 6 months–85 years met protocol requirements for analysis in an observational study on dihydroartemisinin-piperaquine for uncomplicated malaria in Burkina Faso, Ghana, Mozambique, and Tanzania between September 2013 and April 2014.

Burkina Faso · Ghana · Mozambique · Tanzaniepaludismeobservé September 2013 to April 2014publié 2016Malaria journaleurope_pmcdocument de 6 observations

94 patients94 patients were lost to follow-up in an observational study on dihydroartemisinin-piperaquine for uncomplicated malaria in Burkina Faso, Ghana, Mozambique, and Tanzania between September 2013 and April 2014.

Burkina Faso · Ghana · Mozambique · Tanzaniepaludismeobservé September 2013 to April 2014publié 2016Malaria journaleurope_pmcdocument de 6 observations

No significant progress was made in reducing malaria cases between 2015 and 2017.

Ghanapaludismeobservé 2015–2017HAL · Unilimdocument de 40 observations

216 000 000 casesIn 2016, there were an estimated 216 million new cases of malaria and 445,000 deaths.

Ghanapaludismeobservé 2016HAL · Unilimdocument de 40 observations

79 %In Ghana, multivariate regression analysis showed that children with the AS genotype had 79% lower risk of malaria infection compared to those with the AA genotypes.

GhanapaludismeHAL · Unilimdocument de 81 observations

71 %Malaria prevalence in Ghana decreased from 71% in 2000 to about 51% in 2012.

Ghanapaludismeobservé 2000publié 2016Malaria journalPubMeddocument de 4 observations

87,3 %Plasmodium falciparum was prevalent at 87.3% among the 142 malaria-positive participants in Mpraeso, Ghana.

Ghanapaludismeobservé 2014publié 2017Malaria journalPubMeddocument de 4 observations

78,9 %The overall performance in the malaria vaccine implementation programme (MVIP) in Ghana was rated 78.9%.

Ghanapaludismepublié 2024Malaria journalPubMed

20 000 000 casesThere were 20 million fewer malaria cases in 2017 than in 2010.

Ghanapaludismeobservé 2017HAL · Unilimdocument de 40 observations

3 200 000 000 people3.2 thousand million people remain at risk of malaria.

GhanapaludismeHAL · Unilimdocument de 40 observations

880 cases_averted_per_1000_full_dose_equivalentsIn a phase 2b trial in Ghana and Kenya, vaccine impact of the RTS,S malaria vaccine, measured as cumulative number of clinical malaria cases averted per 1000 RTS,S full-dose equivalents at month 32 post-dose 1, was 880 for group Fx017-20-32.

Ghana · Kenyapaludismepublié 2024The Journal of infectious diseasesPubMeddocument de 9 observations

10 %Malaria parasitemia prevalence was 10% among people living with HIV in the urban area of Accra, Ghana.

Ghanapaludismepublié 2018Acta tropicaPubMeddocument de 4 observations